Three nonsense mutations responsible for group A xeroderma pigmentosum

Area of Science:

• Genetics
• Molecular Biology
• Dermatology

Background:

• Xeroderma pigmentosum (XP) group A is a genetic disorder affecting DNA repair.
• The XP-A complementing gene (XPAC) is crucial for DNA repair in XP-A.
• Understanding the molecular basis of XP-A is essential for diagnosis and treatment.

Purpose of the Study:

• To identify and characterize mutations in the XPAC gene in XP-A patients.
• To correlate specific XPAC mutations with clinical phenotypes in XP-A.
• To develop a diagnostic method for XP-A in Japanese populations.

Main Methods:

• Sequencing of the XPAC gene to identify mutations.
• Restriction fragment length polymorphism (RFLP) analysis using specific restriction enzymes.
• Correlation of identified mutations with clinical symptoms and patient ethnicity.

Main Results:

• Three nonsense mutations in the XPAC gene were identified: Arg-228 to TGA, Arg-207 to TGA, and Tyr-116 to TAA.
• The Arg-228 mutation was found in a homozygous patient with mild symptoms, while the Arg-207 mutation was found in a Palestinian patient with severe symptoms.
• The Tyr-116 mutation was identified in two Japanese patients with severe symptoms.
• These three mutations, along with a previously identified splicing mutation, account for almost all Japanese XP-A cases.

Conclusions:

• Clinical heterogeneity in XP-A is linked to distinct mutations in the XPAC gene.
• The identified mutations provide a basis for rapid and reliable diagnosis of XP-A in Japanese patients, including prenatal diagnosis and carrier screening.
• RFLP analysis using HphI, AlwNI, and MseI enzymes offers an efficient diagnostic tool for XP-A.